Status:
RECRUITING
National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders
Lead Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia
Collaborating Sponsors:
Italian Society of Pediatric Allergy & Immunology - Pediatric Centers
Conditions:
Eosinophilic Gastrointestinal Disorders
Eosinophilic Esophagitis
Eligibility:
All Genders
Up to 18 years
Brief Summary
Eosinophilic gastrointestinal disorders (EGIDs) are a heterogeneous group of emerging chronic inflammatory diseases that may affect different gastrointestinal (GI) tracts. Based on the anatomical site...
Eligibility Criteria
Inclusion
- \- All EGIDs patients aged 0-18 years and followed at the centers involved in the study will be considered eligible. Informed consent must be obtained from each enrolled patient and signed by a parent/legal guardian and patient (when older than six years).
Exclusion
- \- This study will not include patients with:
- a diagnosis of EGIDs made more than five years before the study participation;
- a diagnosis of EoE not in line with current international guidelines;
- a secondary cause of intestinal eosinophilic inflammation (inflammatory bowel diseases, autoimmune diseases, vasculitis, graft versus host disease, malignancies).
Key Trial Info
Start Date :
January 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05219903
Start Date
January 20 2022
End Date
January 31 2027
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Policlinico San Matteo
Pavia, Italy, 27100